SCHEMBL2436166

SCHEMBL2436166

COC(=O)Cc1nn2c(c1C(=O)O)CCCC2

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.33
▸ PRMT1 Q99873 5/20 0.33
▸ PRMT6 Q96LA8 1/20 0.33
▸ RXFP1 Q9HBX9 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ GRM5 P41594 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31053394 0.83 HCAR2 (0.35) ALDH1A1PRMT1PRMT6KMT2AMAPK1
SCHEMBL15528192 0.77 KDM4E (0.35) PRMT1PRMT6KMT2AMAPK1RAB9A
SCHEMBL31053388 0.74 ALDH1A1 (0.42) ALDH1A1PRMT1PRMT6KMT2AMAPK1
SCHEMBL29852457 0.73 ALDH1A1 (0.44) ALDH1A1KMT2AMAPK1MAPTRAB9A
SCHEMBL26978255 0.71 KMT2A (0.33) ALDH1A1KMT2AMAPTGAAL3MBTL1
SCHEMBL16708908 0.70 KMT2A (0.31) KMT2AMAPTL3MBTL1MEN1
SCHEMBL23414986 0.69 ALDH1A1 (0.48) ALDH1A1NPSR1KMT2AMAPK1MAPT
SCHEMBL31714739 0.69 ALDH1A1 (0.45) ALDH1A1NPSR1KMT2AMAPK1MAPT
SCHEMBL24173026 0.69 PRMT1 (0.33) PRMT1PRMT6NPSR1
SCHEMBL22275427 0.65 PRMT1 (0.36) PRMT1PRMT6KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547679-B1 2,3 DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.6]NONANE DERIVATIVES AND THEIR USE AS ANTAGONISTS OR INVERSE AGONISTS OF THE GHRELIN RECEPTOR PFIZER (US) 2015-11-04 — — EP disclosed
US-20140080756-A1 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5]NONANE DERIVATIVES PFIZER INC. (US) 2014-03-20 — — US disclosed
US-8609680-B2 2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives PFIZER INC. (US) 2013-12-17 — — US disclosed
EP-2547679-A1 2,3 DIHYDRO-1H-INDEN-1-YL- 2,7-DIAZASPIRO [3.6]NONANE DERIVATIVES AND THEIR USE AS ANTAGONISTS OR INVERSE AGONISTS OF THE GHRELIN RECEPTOR Pfizer Inc. (US) 2013-01-23 — — EP disclosed
WO-2011114271-A1 2,3 DIHYDRO-1H-INDEN-1-YL- 2,7-DIAZASPIRO [3.6] NONANE DERIVATIVES AND THEIR USE AS ANTAGONISTS OR INVERSE AGONISTS OF THE GHRELIN RECEPTOR PFIZER INC. (US) 2011-09-22 — — WO disclosed
US-20110230461-A1 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5] NONANE DERIVATIVES PFIZER INC. 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080756-A1 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5]NONANE DERIVATIVES GIPR, GLP1R, GHSR ALDH1A1 1706/4885PRMT1 412/4885PRMT6 939/4885
US-20110230461-A1 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5] NONANE DERIVATIVES GIPR, GLP1R, GHSR ALDH1A1 1611/4885PRMT1 378/4885PRMT6 872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback